MicroBase has been honored with the 9th National Industrial Innovation Awards presented by MINISTRY OF ECONOMIC AFFAIRS, R.O.C.— a biennial accolade widely regarded as the highest distinction in industrial innovation, often referred to as the "Oscars of Taiwan’s innovation sector."
MicroBase was recognized as one of the few companies in the biomedical and chemical materials sector to receive the award, highlighting its outstanding performance in technological innovation and its contribution to industry advancement.
With a solid foundation in the consumer electronics sector, MicroBase has successfully transitioned into the medical field in recent years, leveraging its robust research and development capabilities to expand into Aerosol Drug Delivery Platform. Through cross-departmental innovation and strategic integration, the company has not only redefined its industrial positioning but also contributed to advancing Taiwan’s healthcare ecosystem by introducing novel, precision-driven therapeutic solutions to the global market.
As the global COVID-19 pandemic resurges and respiratory illnesses such as influenza and respiratory syncytial virus (RSV) become increasingly common, coupled with the ongoing issue of air pollution, the risk of respiratory infections is significantly heightened—especially for infants and the elderly with weaker immune systems.
MicroBase PocketAir aerosol drug delivery platform remains committed to safeguard public health by providing comprehensive and integrated nebulization therapy solutions for patients with chronic respiratory diseases such as bronchitis, asthma, allergies, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis—advancing a more robust and patient-centered healthcare ecosystem.
About the National Industrial Innovation Award
Established by the Ministry of Economic Affairs, the National Industrial Innovation Award centers on the theme of “innovation,” recognizing organizations and individuals that generate value through cultural, technological, and service-driven innovation. The award features diverse categories that honor exemplary achievements in integrated innovation and interdisciplinary collaboration across industry, academia, and research institutions.As a prestigious national commendation, the award celebrates the pioneers and change-makers whose exceptional contributions elevate Taiwan’s industrial competitiveness and deliver tangible impact to society.
Image 1: MicroBase received the National Industrial Innovation Award from Taiwan's Ministry of Economic Affairs for its breakthrough in nebulization medical technology. As the only SME in Taiwan's biomedical and materials sectors to earn the“Outstanding Innovation”honor. (Source: MOEA National Industrial Innovation Award)
Image 2: MicroBase's innovation in aerosol therapy has strengthened domestic medical capabilities and supported industrial advancement. The award was presented by Deputy Minister Mr. C.C. Ho (left), with CEO (right) attending. (Source: MOEA National Industrial Innovation Award)
Image 3: MicroBase continues to drive innovation in respiratory care through its advanced aerosol drug delivery platform. (Source: MOEA National Industrial Innovation Award)
►Economic Daily News ►UDN News
►Commercial Times ►Yahoo Finance
